Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

631 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
Vollbrecht C, Werner R, Walter RF, Christoph DC, Heukamp LC, Peifer M, Hirsch B, Burbat L, Mairinger T, Schmid KW, Wohlschlaeger J, Mairinger FD. Vollbrecht C, et al. Among authors: hirsch b. Br J Cancer. 2015 Dec 22;113(12):1704-11. doi: 10.1038/bjc.2015.397. Epub 2015 Dec 8. Br J Cancer. 2015. PMID: 26645239 Free PMC article.
Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
Hirsch B, Endris V, Lassmann S, Weichert W, Pfarr N, Schirmacher P, Kovaleva V, Werner M, Bonzheim I, Fend F, Sperveslage J, Kaulich K, Zacher A, Reifenberger G, Köhrer K, Stepanow S, Lerke S, Mayr T, Aust DE, Baretton G, Weidner S, Jung A, Kirchner T, Hansmann ML, Burbat L, von der Wall E, Dietel M, Hummel M. Hirsch B, et al. Virchows Arch. 2018 Apr;472(4):557-565. doi: 10.1007/s00428-017-2288-7. Epub 2018 Jan 27. Virchows Arch. 2018. PMID: 29374318 Free PMC article.
Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients.
Sauer S, Erba PA, Petrini M, Menrad A, Giovannoni L, Grana C, Hirsch B, Zardi L, Paganelli G, Mariani G, Neri D, Dürkop H, Menssen HD. Sauer S, et al. Among authors: hirsch b. Blood. 2009 Mar 5;113(10):2265-74. doi: 10.1182/blood-2008-06-160416. Epub 2009 Jan 8. Blood. 2009. PMID: 19131554 Free article.
Immunoglobulin receptor evolution in follicular lymphoma and a review of literature.
Seitz V, Stiege A, Mundlos S, Lenze D, Lammert H, Clermont A, Hirsch B, Von Der Wall E, Müller H, Kirsch A, Diaz-Espada F, Uharek L, Anagnostopoulos I, Stein H, Hummel M. Seitz V, et al. Among authors: hirsch b. Leuk Lymphoma. 2007 Oct;48(10):2063-7. doi: 10.1080/10428190701540983. Leuk Lymphoma. 2007. PMID: 17917975 Review. No abstract available.
Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model.
Menssen HD, Harnack U, Erben U, Neri D, Hirsch B, Dürkop H. Menssen HD, et al. Among authors: hirsch b. J Cancer Res Clin Oncol. 2018 Mar;144(3):499-507. doi: 10.1007/s00432-017-2564-6. Epub 2018 Jan 11. J Cancer Res Clin Oncol. 2018. PMID: 29327244
631 results